Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07059065 · ClinicalTrials.gov registry record · NA
FIBERGRAFT Aeridyan Posterolateral Fusion Study
A NA study of Degenerative Spine Disease, sponsored by DePuy Synthes Products.
- Recruiting
- Registry status
- NA
- Development phase
- 316
- Enrollment target
- 7
- Study locations
NCT07059065 is a NA study of Degenerative Spine Disease that is actively recruiting participants, run by DePuy Synthes Products. The registered enrollment target is 316 participants. The trial reports 7 study locations across 7 states.
The verdict
NCT07059065, a NA study of Degenerative Spine Disease, is actively recruiting participants, sponsored by DePuy Synthes Products.
- RECRUITING
- Registry status
- NA
- Development phase
- 316 participants
- Enrollment target
- 7
- Study locations
Study Summary
This is a post-market, prospective, controlled, multicenter clinical study to evaluate radiographic fusion and clinical outcomes of FIBERGRAFT™ Aeridyan Matrix bone graft substitute in subjects who undergo a 1-3 level instrumented lumbar posterolateral fusion surgery. This clinical study will be conducted at up to 10 clinical sites within the United States.
Conditions Studied
Interventions
- DEVICE FIBERGRAFT™ Aeridyan Matrix Bone Graft Substitute
- DEVICE Demineralized Bone Matrix
Study Locations (7)
California
- UC Davis Health System - Sacramento
Illinois
- University Of Illinois - Chicago
Kentucky
- UK Health Care Kentucky Neuroscience Institute - Lexington
Massachusetts
- Brigham And Women's Hospital - Boston
North Carolina
- Duke University Medical Center - Durham
Pennsylvania
- Rothman Orthopaedics Institute - Philadelphia
Texas
- UT Health Houston - Houston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 316 participants |
| Start Date | 2025-08-15 |
| Est. Completion | 2028-12-29 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07059065
The ClinicalTrials.gov registry entry for NCT07059065 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 316 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is DePuy Synthes Products, which has 3 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Degenerative Spine Disease appearing as the primary indexed condition, and to 2 interventions - of which FIBERGRAFT™ Aeridyan Matrix Bone Graft Substitute is the first listed.
NCT07059065 reports 7 study locations spanning 7 distinct geographic areas - top geographies include California, Illinois, Kentucky.
Frequently Asked Questions
What is clinical trial NCT07059065 about?
NCT07059065 is a clinical study titled "FIBERGRAFT Aeridyan Posterolateral Fusion Study". This is a post-market, prospective, controlled, multicenter clinical study to evaluate radiographic fusion and clinical outcomes of FIBERGRAFT™ Aeridyan Matrix bone graft substitute in subjects who undergo a 1-3 level instrumented lumbar posterolateral fusion surgery. This clinical study will be con...
What is the current status of trial NCT07059065?
This trial is currently recruiting. It is a NA study. The enrollment target is 316 participants. The study started on 2025-08-15. Estimated completion is 2028-12-29.
What conditions does trial NCT07059065 study?
This clinical trial studies the following conditions: Degenerative Spine Disease.
What interventions are being tested in trial NCT07059065?
The interventions under investigation include: FIBERGRAFT™ Aeridyan Matrix Bone Graft Substitute (DEVICE), Demineralized Bone Matrix (DEVICE).
Who is sponsoring clinical trial NCT07059065?
This trial is sponsored by DePuy Synthes Products, which has 3 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07059065 being conducted?
This trial has 7 study locations across California, Illinois, Kentucky, Massachusetts, North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.